Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
04 2021
Historique:
entrez: 6 4 2021
pubmed: 7 4 2021
medline: 6 8 2021
Statut: ppublish

Résumé

The objective of this review is to address the barriers limiting access to treatment of advanced metastatic breast cancer (mBC) in Brazil, specifically for patients in the public health care system, arguably those with the least access to innovation. A selected panel of Brazilian experts in BC were provided with a series of relevant questions to address in a multiday conference. During the conference, responses were discussed and edited by the entire group through numerous drafts and rounds of discussion until a consensus was achieved. The authors propose specific and realistic recommendations for implementing access to new drugs in cancer care in Brazil. Moreover, in creating these recommendations and framework, the authors strive to address the most important barriers and impediments for technology incorporation. A feasible and specific multidisciplinary process is proposed, which is based on the collective participation of all involved stakeholders. Given the current benefits and likely future developments, there is a great need to expand treatments for mBC not only in Brazil but also in most other countries in the world where access issues remain an unresolved demand. Adapting the current framework is essential for accomplishing this goal. The recommendations in this review can serve as a framework for adoption of new technologies in countries with limited resources.

Identifiants

pubmed: 33822641
doi: 10.1200/GO.20.00566
pmc: PMC8081546
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-485

Références

BMC Cancer. 2019 Oct 23;19(1):987
pubmed: 31647005
Value Health. 2008 Jul-Aug;11(4):771-83
pubmed: 18179658
Breast J. 2015 Sep-Oct;21(5):567-9
pubmed: 26227263
Curr Med Res Opin. 2014 Jun;30(6):1007-16
pubmed: 24490834
Cad Saude Publica. 2017 May 18;33(4):e00040717
pubmed: 28538787
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2673-9
pubmed: 20716620
Lancet. 2019 Jul 27;394(10195):345-356
pubmed: 31303318
JAMA Oncol. 2020 Jan 01;6(1):116-124
pubmed: 31563959
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Rev Gaucha Enferm. 2018 Oct 18;39:e20180014
pubmed: 30365759
Cad Saude Publica. 2015 Jul;31(7):1539-50
pubmed: 26248108
Health Hum Rights. 2016 Jun;18(1):209-220
pubmed: 27781011
Lancet Oncol. 2018 Jul;19(7):904-915
pubmed: 29804902
N Engl J Med. 2019 Jul 25;381(4):307-316
pubmed: 31166679
Eur J Cancer. 2018 May;95:93-101
pubmed: 29655061
Rev Saude Publica. 2017 Jun 01;51(suppl 1):14s
pubmed: 28591356
Soc Sci Med. 2015 Jan;124:39-47
pubmed: 25461860
Int J Equity Health. 2016 Nov 17;15(1):136
pubmed: 27852313
Cad Saude Publica. 2015 Aug;31(8):1673-84
pubmed: 26375646
Prev Med. 2011 Mar-Apr;52(3-4):285-6
pubmed: 21354203
Clin Breast Cancer. 2018 Aug;18(4):e613-e619
pubmed: 29275865
BMC Womens Health. 2017 Feb 21;17(1):13
pubmed: 28222726
Cien Saude Colet. 2017 Dec;22(12):4073-4082
pubmed: 29267724
Clin Breast Cancer. 2018 Aug;18(4):e651-e658
pubmed: 29239835
Nature. 2018 Mar;555(7695):S26-S29
pubmed: 32095016
BMJ Open. 2017 Aug 23;7(8):e016395
pubmed: 28838894
Rev Panam Salud Publica. 2017 Dec 05;41:e168
pubmed: 31391844
Cancer. 2018 Dec 15;124(24):4700-4710
pubmed: 30329152
JCO Glob Oncol. 2020 Feb;6:307-312
pubmed: 32109156
PLoS One. 2018 Aug 2;13(8):e0200125
pubmed: 30071031
Int J Equity Health. 2019 Jun 13;18(1):88
pubmed: 31196095
Rev Bras Epidemiol. 2012 Dec;15(4):737-47
pubmed: 23515770
Biotechnol Healthc. 2004 May;1(2):42-4
pubmed: 23372498
Curr Med Res Opin. 2014 Aug;30(8):1537-45
pubmed: 24669852
Breast Cancer Res. 2004;6(6):229-39
pubmed: 15535852
Rev Saude Publica. 2005 Jun;39(3):340-9
pubmed: 15997308
Cien Saude Colet. 2019 May 30;24(5):1709-1722
pubmed: 31166506
J Prim Care Community Health. 2017 Jul;8(3):169-175
pubmed: 28606031
Cad Saude Publica. 2011 Dec;27(12):2364-72
pubmed: 22218579
Rural Remote Health. 2013 Apr-Jun;13(2):2321
pubmed: 23597169
Cad Saude Publica. 2015 Jun;31(6):1269-82
pubmed: 26200374
Ann Oncol. 2016 Feb;27(2):256-62
pubmed: 26578730
Cad Saude Publica. 2008 Aug;24(8):1783-90
pubmed: 18709219
Rev Col Bras Cir. 2017 Jul-Aug;44(4):316-322
pubmed: 29019533
Cad Saude Publica. 2005;21 Suppl:78-88
pubmed: 16462999
Lancet Glob Health. 2019 Jun;7(6):e784-e797
pubmed: 31097280
Rev Saude Publica. 2019 Jan 31;53:14
pubmed: 30726495
Breast. 2019 Apr;44:113-119
pubmed: 30738289
Rev Bras Ginecol Obstet. 2018 Mar;40(3):127-136
pubmed: 29510437
Oncotarget. 2017 May 9;8(42):71548-71555
pubmed: 29069727
Lancet Oncol. 2016 Apr;17(4):425-439
pubmed: 26947331
Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e29-e36
pubmed: 28988891
N Engl J Med. 2020 Feb 6;382(6):514-524
pubmed: 31826360
Appl Health Econ Health Policy. 2017 Jun;15(3):307-321
pubmed: 28063134
Cad Saude Publica. 2009;25 Suppl 2:S310-20
pubmed: 19684938
N Engl J Med. 2016 Nov 17;375(20):1925-1936
pubmed: 27959613
BMC Public Health. 2017 Mar 14;17(1):253
pubmed: 28288609
Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):126-33
pubmed: 24165578
N Engl J Med. 2015 Jul 16;373(3):209-19
pubmed: 26030518
Cad Saude Publica. 2007 Jul;23(7):1665-73
pubmed: 17572816
Cancer Treat Res Commun. 2020 Apr 23;23:100175
pubmed: 32361352
Ann Oncol. 2018 Jul 1;29(7):1541-1547
pubmed: 29718092
Cad Saude Publica. 2008 Nov;24(11):2623-32
pubmed: 19009142
Rev Bras Epidemiol. 2016 Mar;19(1):1-13
pubmed: 27167644
PLoS One. 2018 Nov 26;13(11):e0207993
pubmed: 30475890
Epidemiology. 2006 Sep;17(5):512-9
pubmed: 16804473
J Clin Oncol. 2019 Feb 1;37(4):336-349
pubmed: 30707056
Cad Saude Publica. 2009 Jul;25(7):1493-500
pubmed: 19578570
Cien Saude Colet. 2015 Oct;20(10):3163-76
pubmed: 26465858
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Rev Bras Epidemiol. 2013 Dec;16(4):930-42
pubmed: 24896598
Rev Assoc Med Bras (1992). 2017 Jan 1;63(1):35-42
pubmed: 28225871
J Clin Oncol. 2018 Aug 20;36(24):2465-2472
pubmed: 29860922
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249
pubmed: 31590149
BMC Womens Health. 2014 Aug 29;14:102
pubmed: 25174527
Maturitas. 2015 Dec;82(4):365-70
pubmed: 26358931
J Clin Oncol. 2017 Sep 1;35(25):2875-2884
pubmed: 28580882
J Manag Care Spec Pharm. 2017 Oct;23(10):1010-1015
pubmed: 28944729
Breast. 2014 Apr;23(2):180-7
pubmed: 24503143

Auteurs

Carlos Barrios (C)

Grupo Oncoclínicas, Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.

Ruffo Freitas-Junior (R)

CORA, Advanced Center for Diagnosis of Breast Diseases, Federal University of Goias, Goiânia, Brazil.
Araujo Jorge Hospital of Associação de Combate ao Câncer em Goiás, Goiânia, Brazil.

Sandro Martins (S)

Medical Oncology Unit, University Hospital of Brasília/EBSERH, Brasília, Brazil.

Jose Bines (J)

Clínica São Vicente, Rio de Janeiro, Brazil.

Maria Del Pilar Estevez-Diz (MDP)

Instituto do Câncer do Estado de São Paulo/Faculdade de Medicina da Universidade de São Paulo, Onco Star Rede D'Or, São Paulo, Brazil.

Maira Caleffi (M)

Hospital Moinhos de Vento, Femama, Porto Alegre, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH